http://www.fda.gov/cder/orange/appendix_a.txt 3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt API DIVISION" "AMOXICILLIN MFG IN MEXICO, MISSOURI" 13520 01-Sep-98 ANTIBIOTICOS TETRACYCLINE PHOSPHATE COMPLEX 13521 01-Sep-98 KYOWA HAKKO MITOMYCIN 13523 01-Sep-98 GIST BROCADES (IT) NYSTATIN 13527 01-Sep-98 BRISTOL MYERS SQUIBB INDUSTRIAL DIV AMIKACIN SULFATE 13535 01-Sep-98 MEIJI SEIKA KAISHA L PENICILLIN G PROCAINE 13536 01-Sep-98 ALPHARMA APS POLYMYXIN B SULFATE AS MANUFACTURED...
OGD Suitability Tracking Reports (Sorted by Petition Number) as of 1/5/2004 FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -OGD Suitability Tracking Report (Sorted by Petition Number) as of 1/5/2004 Drug/Strength Petition No/Firm Dosage Form Status Status Date ACETAMINOPHEN 300 MG HYDROCODONE BITARTRATE 5 MG, 7.5 MG, 10 MG - 03P-0436/CP1 ANABOLIC LABORATORIES - - - 9/22/2003- TRIPELENNAMINE HYDROCHLORIDE 25 MG/5...
OGD Suitability Tracking Reports (Sorted by Drug Name) as of 1/5/2004 FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -OGD Suitability Tracking Report (Sorted by Drug Name) as of 1/5/2004 Drug/Strength Petition No/Firm Dosage Form Status Status Date ACETAMINOPHEN 200MG;200MG; 200MG HYDROCODONE BITARTRATE 5MG;7.5MG;10MG - 02P-0004/CP1 SHOTWELL AND CARR, INC
Prescription and Over-the-Counter Drug Product List: 10/2003 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE SOLUTION; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> AA VINTAGE PHARMS 500MG/15ML;7.5MG/15ML N40520 001 OCT 30, 2003 OCT NEWA TABLET; ORAL ANEXSIA >D> AA MALLINCKRODT 750MG;10MG N40468 001 OCT 31, 2002 OCT CTNA >A> AA 750MG;10MG N40468 001 OCT 31, 2002 OCT CTNA ALBUTEROL SULFATE TABLET...
Prescription and Over-the-Counter Drug Product List: 3/2003 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE; ORAL FIORICET W/ CODEINE -D- AB + NOVARTIS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN -A- AB + WATSON PHARMS 325MG;50MG;40MG;30MG N20232 001 JUL 30, 1992 MAR CAHN ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL CODRIX -A- + ANDRX PHARMS 500MG;30MG N40441 001...
author: AUTHOR
Patent Patent Status – PCT Patent Pub. Date Filed Title WO02051408A1 07/04/2002 12/21/2001 AZOLE COMPOUNDS AS ANTI-FUNGALS AGENTS WO0247607A2 06/20/2002 12/07/2001 PROCESS FOR THE PREPARATION OF A FAST ...
ranbaxy - -- - - - - You are here :- Home - News Room - - Press Releases - December 2000 Ranbaxy receives FDA approvals for 4 ANDA's representating 9 formulations in the US December 04, 2000, New Delhi Ranbaxy ...
Prescription and OTC Drug Product List 9/1999 Prescription and Over-the-Counter Drug Product List - 19th Edition Cumulative Supplement Number 9: September 1999 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE ATENOLOL CAPSULE; ORAL TABLET; ORAL - DLT - BUTALBITAL, ACETAMINOPHEN, CAFFEINE ATENOLOL - DLT - AB GRAHAM DM 325MG;50MG;40MG N88758 001 - ADD - MYLAN 25MG...
Prescription and OTC Drug Product List 6/1999 Prescription and Over-the-Counter Drug Product List - 19th Edition Cumulative Supplement Number 6: June 1999 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE AMINO ACIDS TABLET; ORAL INJECTABLE; INJECTION PERCOCET NOVAMINE 8.5% - ADD - AA ENDO PHARMS 325MG;5MG N40330 002 - DLT - @ PHARMACIA AND UPJOHN 8.5% N17957 002...
Prescription and OTC Drug Product List 5/2001 Prescription and Over-the-Counter Drug Product List - 21st Edition Cumulative Supplement Number 5: January-May 2001 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; ASPIRIN; CODEINE PHOSPHATE - ADD - ALMOTRIPTAN MALATE CAPSULE; ORAL - ADD - TABLET; ORAL ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE - ADD - AXERT - DLT - + MIKART 150MG;180MG...
ranbaxy - -- - - - - You are here :- Home - News Room - - Press Releases - Sales up 24 %, operating Profit up 26.5 % Sales up 24 %, operating Profit up 26.5 % New Delhi July 29,1999 The Board of Directors of Ranbaxy ...
http://www.allergan.com/assets/pdf/MSDS/ehs-estrasorb.pdf December 21, 2007 ESTRASORB ® Estradiol Topical Emulsion Page 1 of 5 aaALLERGAN SAFETY DATA SHEET NFPA Rating: Health: 1 Flammability: 2 Reactivity: 0 Special: 0 TELEPHONE CONTACTS: Product Technical and Medical Information: (800) 433- 8871 Transportation Emergency 24- Hour Response (CHEMTREC): (800) 424- 9300 S E C T I O N 1 : P R O D U C T I D E N T I F I C A T I O N Compound...
http://www.allergan.com/assets/pdf/MSDS/ehs-estrasorb.pdf page 2
http://www.biomet.com/hcp/filedownload.cfm?from=p&id=09070202 page 6
duplicates:http://www.biomet.com/surgeons/products/filedownload.cfm?d=09070202 http://www.biomet.com/products/filedownload.cfm?d=09070202 http://www.biomet.com/education/filedownload.cfm?d=09070202
Database A A - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products.
http://www.fda.gov/cder/dmf/text/4Q2003NEWTEXT.txt CHINA." 16892 V 3-Sep-2003 ALTHEA TECHNOLOGIES INC "ASEPTIC FORMULATION, FILL, AND FINISH FACILITY IN SAN DIEGO, CA." 16893 III 15-Sep-2003 ERIE MOLDED PLASTICS INC "LID FOR DEODORANT AS MANUFACTURED IN ERIE, PA." 16894 II 5-Oct-2003 DIVIS LABORATORIES LTD "LEVITERACETAM AS MANUFACTURED IN ANDHRA PRADESH, INDIA." 16895 IV 6-Oct-2003 FIRMENICH INC "NATURAL & ARTIFICIAL ORANGE FLAVOR...
http://www.fda.gov/cder/dmf/xls/4Q2003NEWEXCEL.xls Arthur Shaw CDER User $ ($) $ ($) $ ($) $ ($) $ $ () $ - () - $ $ () $ - () - -- -- $ ($) $ ($) $ ($) $ ($) / / // -- - - : : :: : () () () () () - $ $ () $ - () - $ $ () $ - : :: : 4Q2003NEWEXCEL DMF # Type SUBMIT DATE HOLDER SUBJECT IV COGNIS DEUTSCHLAND GMBH CO KG MYRITOL(R) 318 PH AS MANUFACTURED IN DUESSELDORF, GERMANY
Apotex Inc - PressReleases Attention: News/Business Editors March 4, 2003 For Immediate Release Apotex Wins Key Battle Over Generic Paxil® Court Victory on Hemihydrate Patent Clears Key Hurdle WESTON, FLORIDA, U.S.A – Apotex Corp
Apotex Inc - PressReleases body { scrollbar-face-color: #006BA8; scrollbar-shadow-color: Black; scrollbar-highlight-color: White; scrollbar-3dlight-color: #000000; scrollbar-darkshadow-color: #FFFCC; scrollbar-track-color: #E0E1E9; scrollbar-arrow-color: #FFFFCC; } Select a Country Aruba Bahamas Bahrain Barbados Belarus Bermuda Botswana Brazil Canada (English) Canada (Francais) Cayman Islands China Costa Rica...
Apotex Inc - PressReleases November 3, 2003 The Apotex Group Donates $1.5 Million To Laval University's Faculty of Pharmacy QUEBEC CITY, CANADA– The Apotex Group today announced a $1.5 million donation to Laval University’s- Faculty of Pharmacy
Apotex Inc - PressReleases body { scrollbar-face-color: #006BA8; scrollbar-shadow-color: Black; scrollbar-highlight-color: White; scrollbar-3dlight-color: #000000; scrollbar-darkshadow-color: #FFFCC; scrollbar-track-color: #E0E1E9; scrollbar-arrow-color: #FFFFCC; } Select a Country Aruba Bahamas Bahrain Barbados Belarus Bermuda Botswana Brazil Canada (English) Canada (Francais) Cayman Islands China Costa Rica...
patcrystalSub.dvi page 28
duplicates:http://www.fda.gov/cder/OPS/patcrystalSub.pdf
http://www.fda.gov/cdrh/pdf3/k031319.pdf JUb 1 7 2003 510( k) Summary ASpine USA Osteo- G Bone Void Filler System ADMINISTRATIVE INFORMATION Manufacturer Name: Official Contact: ASpine USA 3645 Grand Avenue, Suite 104 Oakland, CA 946 1 0 Gordon Tao PresidentCEO Telephone (5 10) 25 1- 6798 FAX (5 10) 25 1- 6262 Representative/ Consul tant: Floyd G
http://www.fda.gov/cdrh/pdf3/k031319.pdf page 2
